Search
for
Sort by
Research 181–210 of 1000+
- A Real‐World Disproportionality Analysis of Avacopan in Anti‐Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System
- Citalopram and finasteride with the lot number FI0510058-A have been voluntarily recalled by Greenstone, after a labelling error
- How routine pharmacovigilance failed to identify finasteride’s persistent sexual side effects
- Off-label prescriptions: patient safety first
- The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA
- Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation
- 836 Applying FACS-based single cell RNA-seq to study neonatal mouse skin
- The safety profiles of avacopan on microscopic polyangiitis and granulomatosis with polyangiitis: a real-world pharmacovigilance analysis
- Exploring novel management options for alopecia areata
- Mining and analysis of adverse event signals of isotretinoin based on the real-world data of FAERS database
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Reporting on Adverse Clinical Events
- The Potential Role of Minoxidil in the Hair Transplantation Setting
- Androgenetic alopecia – Current status
- Finasteride in Androgenic Alopecia
- Cardiovascular Safety Signals of Oral Versus Topical Minoxidil in FAERS: A Disproportionality Analysis (Analytic Cohort 2012–2025)
- Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis
- Contraception and the dermatologist
- Nurses' Drug Alert
- Reporting on Adverse Clinical Events
- An Overview of Herbal Ingredients with Anti-dandruff Activity in Shampoo Formulations
- Antioxidant and Antiproliferative Activity of Finasteride against Glioblastoma Cells
- Review on Alopecia Areata in the Middle East and Africa: Landscape and Unmet Needs
- Evolving CRBN ligands enhance the drug-like properties of protein degraders
- The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis
- Hepatotoxicity Secondary to A Drug to Lose Weight, "Orlistat": to take into Account as a Differential Diagnosis
- Topical ketoconazole: a systematic review of current dermatological applications and future developments
- A regulatory perspective on pharmacokinetic/pharmacodynamic modelling